Related Experiment Videos
Antithrombin and anti-Xa agents in the control of thrombogenesis
J Fareed1, T Shaikh, D A Hoppensteadt
1Departments of Pathology and Pharmacology, Loyola University Chicago, Maywood, IL, USA. jfareed@lumc.edu
Die Pharmazie
|November 1, 2001
Abstract:
Recent developments as well as future trends in the area of thrombin inhibitors and anti-Xa agents are reviewed.
Insights
This review covers recent advancements and future directions for thrombin inhibitors and anti-factor Xa (anti-Xa) agents, crucial for anticoagulation therapy.
Area of Science:
- Pharmacology
- Biochemistry
- Hematology
Background:
- Thrombin inhibitors and anti-Xa agents are critical anticoagulants.
- Understanding their mechanisms is vital for managing thrombotic disorders.
Purpose of the Study:
- To review recent developments in thrombin inhibitors and anti-Xa agents.
- To discuss future trends in the field of anticoagulation.
Main Methods:
- Literature review of recent scientific publications.
- Analysis of current research and clinical trial data.
- Synthesis of information on drug development and therapeutic applications.
Main Results:
- Overview of novel direct thrombin inhibitors and direct anti-Xa agents.
- Discussion of emerging targets and drug delivery systems.
- Identification of key challenges and opportunities in anticoagulation therapy.
Conclusions:
- The field of anticoagulation is rapidly evolving with new therapeutic options.
- Continued research is necessary to optimize the use of these agents and address unmet clinical needs.